查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827700

2025年全球分叉病变市场报告

Bifurcation Lesions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，分叉病变市场规模强劲成长，从2024年的26.3亿美元增加至2025年的28.4亿美元，复合年增长率达7.8%。这段时期的成长归因于冠状动脉疾病盛行率的上升、老年人口的成长、医疗支出的增加、经济成长。

预计未来几年分叉病变市场规模将强劲成长，到2029年将达到40.1亿美元，复合年增长率为9.1%。预测期内的成长归因于微创手术需求的不断增长、医疗基础设施和设施的扩建、心血管疾病盛行率的上升以及政府医疗政策的出台。预测期内的主要趋势包括以患者为中心的治疗方法、生物可吸收支架、人工智慧和机器学习的整合以及跨学科合作。

冠状动脉分叉病变是指邻近或涉及重要侧支起始处的动脉发生狭窄，而该侧支原本应予以保留。当斑块积聚导致动脉狭窄，阻碍血液流向心臟时，就会发生这种情况。

分叉病灶主要分为单支架入路和双支架入路。在单支架分叉病变手术中，如果根据临床症状、血管造影术结果或其他相关因素认为需要干预，则在侧支中暂时放置支架。在这种方法中，首先在主支中置入支架。分叉角由主支和侧支的内角决定。这类分叉病变常见于冠状动脉和周边血管。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 全新报告系列的一部分，该系列提供分叉病变市场统计数据，例如全球市场规模、区域份额、竞争对手的分叉病变市场份额、详细的分叉病变细分市场、市场趋势和机会，以及您在分叉病变行业取得成功所需的数据。本分叉病变市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切全面观点。

未来五年的预测成长率为9.1%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响透过对义大利和荷兰的专用导管导引线和药物涂层球囊征收关税直接影响美国，可能导致复杂冠状动脉手术的供不应求。

预计分叉病市场的成长将受到老年人口不断增长的推动。 60 岁及以上的人更容易患心臟病、中风、心臟疾病和心臟衰竭等心臟相关疾病。分叉病在治疗此类情况下的血栓和促进心臟充足的血液流动方面起着关键作用。根据世界卫生组织 (WHO) 的报告，到 2030 年，全球六分之一的人将年满 60 岁或以上，而到 2050 年，80 岁及以上人口的数量预计将比现在增加 4.26 亿。不断增长的老年人口预计将成为分叉病市场的主要驱动力。

预计未来几年，不断增长的医疗支出将推动分叉病变市场的成长。医疗基础设施涵盖与医疗保健、预防措施、公共卫生活动、復健、社区健康活动、健康监测等相关的所有费用。不断增长的医疗支出使医疗机构能够投资尖端设备和技术，例如先进的介入性心臟病学设备，以治疗分叉病变。例如，2023年11月，总部位于加拿大的非营利组织加拿大卫生资讯研究所预测，继2022年仅温和成长1.5%之后，2023年加拿大的医疗保健总支出将增加2.8%。因此，不断增长的医疗支出正在推动分叉病变市场的成长。

推动分叉病变市场发展的关键趋势之一是影像和手术器械的进步。市场主要企业正致力于增强现有的影像和手术器械。例如，临床阶段医疗设备公司 Advanced Bifurcation Systems (ABS) 开发了一种独特的分叉支架解决方案，该方案采用模组化自对准支架技术。该平台旨在标准化冠状动脉血管成形术中所有分叉病变的治疗，提供单一系统，减少再次手术的需求，并实现高效的分叉支架植入。器械的进步趋势正在推动分叉病变市场的成长和创新。

分叉病变市场的主要企业正在积极开发创新产品，例如药物释放型冠状动脉支架系统，以扩大基本客群、增加销售并推动收益成长。药物释放型冠状动脉支架系统是用于介入性心臟病学治疗冠状动脉疾病的专用医疗设备。 2023 年 8 月，爱尔兰医疗设备製造商Medtronic力公司推出了 Onyx Frontier药物释放型支架 (DES)，用于使用临时支架治疗非左主干分叉病变。该产品具有几项设计改进，包括双层球囊、减少的横截面和提高的导管灵活性。与上一代 Resolute Onyx DES 相比，这些改进将输送能力提高了 16%，同时保持了相同的径向强度。 Onyx Frontier 有多种尺寸可供选择，从 2.0 毫米到 5.0 毫米，具有专门的尺寸来满足患者对治疗非常大的血管（包括左主干）的需求。该产品继承了Resolute Onyx的临床数据和适应症，包括核准用于治疗分叉核准、左主干经皮冠状动脉介入治疗（PCI），以及建议用于高出血风险患者的一个月双重抗血小板治疗（DAPT）。

2024年6月，美国医疗科技公司波士顿科学公司（Boston Scientific Corporation）以11.8亿美元收购了丝路医疗公司（Silk Road Medical）。此次收购旨在增强波士顿科学公司在血管市场的产品阵容和竞争地位，利用创新技术改善患者治疗效果并扩大新市场。丝路医疗是一家专注于开发颈动脉手术创新解决方案的医疗设备製造商。

分叉病变市场的主要公司包括波士顿科学公司、泰尔茂医疗公司、Spectranetics 公司、Medtronic力公司、康德乐公司、康德乐公司、雅培实验室、Biosensors 国际集团有限公司、B. Braun Terumo Corporation AG、Cook Medical LLC、Cordis 公司、Endologics 公司、W.L. Gore & AssociatesC、Inspire & AssociatesC. KG、Cardionovum GmbH、Elixir Medical 公司、Medinol 有限公司、Meril Life Sciences Pvt. 有限公司、Opto Circuits (India) 有限公司、QualiMed Innovative Medizinprodukte GmbH 和 Sahajanand Medical Technologies Pvt。 Ltd.、Svelte Medical Systems Inc.、Translumina GmbH、Vascular Concepts Limited、Vascular Solutions Inc.、Veryan Medical Ltd.、X-Cell Medical Inc.、Zorion Medical Inc.、Amaranth Medical Inc.、Cardiomind Inc.、Cardiva Medical Inc.

2024年，北美是分叉病变市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。分叉病变市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

分叉病变市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

分叉病变市场包括近端主支 (MB)、远端主支 (MB) 和侧支 (SB) 的收益。市场价值包括服务供应商销售或包含在服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球分歧：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球分岔病变市场：增长率分析
  • 全球分叉病变市场表现：规模与成长，2019-2024
  • 全球分叉病变市场预测：2024-2029年及2034年规模与成长
  • 全球分叉病变：总可寻址市场（TAM）

第六章 市场细分

  • 全球分叉病变市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 一个支架
  • 2个支架
  • 全球分叉病变市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 冠状动脉血管
  • 週边血管
  • 全球分叉病变市场：按单支架类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 单支架置入
  • 球囊扩张型支架
  • 自动扩张型支架
  • 全球分叉病变市场：细分 2：支架（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 粉碎技术
  • T形或Y形支架
  • 侧支支架置入术

第七章 区域和国家分析

  • 全球分叉病变市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球分叉病变市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 分叉病变市场：竞争格局
  • 分叉病变市场：公司简介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Cardinal Health Company
  • Abbott Laboratories
  • Biosensors International Group Ltd.
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Cordis Corporation
  • Endologix Inc.
  • WL Gore & Associates Inc.
  • InspireMD Inc.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • Biotronik SE & Co. KG
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Medinol Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年分叉病变市场：提供新机会的国家
  • 2029年分叉病变市场：细分领域带来新机会
  • 2029年分叉病变市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21137u

Bifurcation lesions in the context of coronary arteries refer to constrictions that occur adjacent to or involve the origin of a critical side branch that one aims to preserve. This situation arises when there is an accumulation of plaque deposits, causing the artery to become too narrow, thereby hindering adequate blood flow to the heart.

The main categorizations of bifurcation lesions are one-stent and two-stent approaches. In a one-stent bifurcation lesion procedure, the side branch is provisionally stented if intervention is deemed necessary based on clinical complaints, angiographic results, or other relevant factors. In this approach, the main branch is stented first. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are encountered in both coronary and peripheral vascular contexts.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides bifurcation lesions market statistics, including bifurcation lesions industry global market size, regional shares, competitors with a bifurcation lesions market share, detailed bifurcation lesions market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. This bifurcation lesions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration.

The forecast of 9.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on specialized guidewires and drug-coated balloons from Italy and the Netherlands, potentially causing supply shortages for complex coronary procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the bifurcation lesions market is expected to be driven by the increasing geriatric population. Individuals aged 60 and above are more susceptible to heart-related issues such as heart attacks, strokes, coronary heart disease, and heart failure. Bifurcation lesions play a crucial role in treating blood clots and facilitating adequate blood flow to the heart in such cases. A report by the World Health Organization (WHO) projected that by 2030, one in six people globally would be 60 or older, and by 2050, the number of individuals aged 80 and above would increase by 426 million compared to the current population. The rise in the geriatric population is anticipated to be a significant driver for the bifurcation lesions market.

The rising healthcare expenditure is expected to drive the growth of the bifurcation lesions market in the future. Healthcare infrastructure encompasses all expenses related to medical care, preventive measures, public health initiatives, rehabilitation, community health activities, and health research. Increased healthcare spending enables healthcare facilities to invest in cutting-edge equipment and technologies, including advanced interventional cardiology devices for treating bifurcation lesions. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization based in Canada, projected that total health spending in Canada would increase by 2.8% in 2023, following a modest growth of only 1.5% in 2022. Consequently, the rising healthcare expenditure is propelling the growth of the bifurcation lesions market.

A key trend gaining popularity in the bifurcation lesions market is the advancement in devices used in imaging and procedures. Leading companies in the market are focusing on enhancing existing devices used in imaging and procedures. For example, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm, has developed a unique bifurcation stenting solution featuring modular self-aligning stent technology. This platform aims to standardize the treatment of all bifurcation lesions in coronary angioplasties, providing a single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment. The trend towards device advancement is contributing to the growth and innovation in the bifurcation lesions market.

Leading companies in the bifurcation lesions market are actively developing innovative products such as drug-eluting coronary stent systems to expand their customer base, increase sales, and drive revenue growth. A drug-eluting coronary stent system is a specialized medical device used in interventional cardiology for the treatment of coronary artery disease. In August 2023, Medtronic PLC, an Ireland-based medical device company, introduced the Onyx Frontier drug-eluting stent (DES) to address non-left main bifurcation lesions using the provisional stenting technique. This product incorporates several design enhancements, including a dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility. The improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, maintaining the same level of radial strength. Onyx Frontier offers an extensive range of sizes, accommodating patient needs with diameters ranging from 2.0mm to 5.0mm, with specific sizing for the treatment of extra-large vessels, including those in the left main. The product inherits clinical data and indications from Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

In June 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.18 billion. The acquisition aims to enhance Boston Scientific's product offerings and competitive position in the vascular market by leveraging innovative technologies to improve patient outcomes and expand into new markets. Silk Road Medical, Inc. is a medical device firm that focuses on developing innovative solutions for carotid artery procedures.

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bifurcation lesions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bifurcation lesions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bifurcation Lesions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bifurcation lesions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bifurcation lesions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bifurcation lesions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: One-Stent; Two-Stent
  • 2) By Application: Coronary Vascular; Peripheral Vascular
  • Subsegments:
  • 1) By One-Stent: Single-Stent Deployment; Balloon-Expandable Stents; Self-Expanding Stents
  • 2) By Two-Stent: Crush Technique; T- or Y-Configuration Stenting; Side Branch Stenting Techniques
  • Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation; Spectranetics Corporation; Medtronic plc; Cardinal Health Inc.; Cardinal Health Company; Abbott Laboratories; Biosensors International Group Ltd.; B. Braun Melsungen AG; Cook Medical LLC; Cordis Corporation; Endologix Inc.; W. L. Gore & Associates Inc.; InspireMD Inc.; MicroPort Scientific Corporation; OrbusNeich Medical Company Limited; Biotronik SE & Co. KG; Cardionovum GmbH; Elixir Medical Corporation; Medinol Ltd.; Meril Life Sciences Pvt. Ltd.; Opto Circuits (India) Ltd.; QualiMed Innovative Medizinprodukte GmbH; Sahajanand Medical Technologies Pvt. Ltd.; Svelte Medical Systems Inc.; Translumina GmbH; Vascular Concepts Limited; Vascular Solutions Inc.; Veryan Medical Ltd.; X-Cell Medical Inc.; Zorion Medical Inc.; Amaranth Medical Inc.; Cardiomind Inc.; Cardiva Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bifurcation Lesions Market Characteristics

3. Bifurcation Lesions Market Trends And Strategies

4. Bifurcation Lesions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bifurcation Lesions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bifurcation Lesions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bifurcation Lesions Market Growth Rate Analysis
  • 5.4. Global Bifurcation Lesions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bifurcation Lesions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bifurcation Lesions Total Addressable Market (TAM)

6. Bifurcation Lesions Market Segmentation

  • 6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • One-Stent
  • Two-Stent
  • 6.2. Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Vascular
  • Peripheral Vascular
  • 6.3. Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Stent Deployment
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • 6.4. Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crush Technique
  • T- or Y-Configuration Stenting
  • Side Branch Stenting Techniques

7. Bifurcation Lesions Market Regional And Country Analysis

  • 7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bifurcation Lesions Market

  • 8.1. Asia-Pacific Bifurcation Lesions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bifurcation Lesions Market

  • 9.1. China Bifurcation Lesions Market Overview
  • 9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bifurcation Lesions Market

  • 10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bifurcation Lesions Market

  • 11.1. Japan Bifurcation Lesions Market Overview
  • 11.2. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bifurcation Lesions Market

  • 12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bifurcation Lesions Market

  • 13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bifurcation Lesions Market

  • 14.1. South Korea Bifurcation Lesions Market Overview
  • 14.2. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bifurcation Lesions Market

  • 15.1. Western Europe Bifurcation Lesions Market Overview
  • 15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bifurcation Lesions Market

  • 16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bifurcation Lesions Market

  • 17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bifurcation Lesions Market

  • 18.1. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bifurcation Lesions Market

  • 19.1. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bifurcation Lesions Market

  • 20.1. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bifurcation Lesions Market

  • 21.1. Eastern Europe Bifurcation Lesions Market Overview
  • 21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bifurcation Lesions Market

  • 22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bifurcation Lesions Market

  • 23.1. North America Bifurcation Lesions Market Overview
  • 23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bifurcation Lesions Market

  • 24.1. USA Bifurcation Lesions Market Overview
  • 24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bifurcation Lesions Market

  • 25.1. Canada Bifurcation Lesions Market Overview
  • 25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bifurcation Lesions Market

  • 26.1. South America Bifurcation Lesions Market Overview
  • 26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bifurcation Lesions Market

  • 27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bifurcation Lesions Market

  • 28.1. Middle East Bifurcation Lesions Market Overview
  • 28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bifurcation Lesions Market

  • 29.1. Africa Bifurcation Lesions Market Overview
  • 29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

  • 30.1. Bifurcation Lesions Market Competitive Landscape
  • 30.2. Bifurcation Lesions Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bifurcation Lesions Market Other Major And Innovative Companies

  • 31.1. Cardinal Health Company
  • 31.2. Abbott Laboratories
  • 31.3. Biosensors International Group Ltd.
  • 31.4. B. Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Cordis Corporation
  • 31.7. Endologix Inc.
  • 31.8. W. L. Gore & Associates Inc.
  • 31.9. InspireMD Inc.
  • 31.10. MicroPort Scientific Corporation
  • 31.11. OrbusNeich Medical Company Limited
  • 31.12. Biotronik SE & Co. KG
  • 31.13. Cardionovum GmbH
  • 31.14. Elixir Medical Corporation
  • 31.15. Medinol Ltd.

32. Global Bifurcation Lesions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

34. Recent Developments In The Bifurcation Lesions Market

35. Bifurcation Lesions Market High Potential Countries, Segments and Strategies

  • 35.1 Bifurcation Lesions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bifurcation Lesions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bifurcation Lesions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer